Thompson Investment Management, Inc. Astrazeneca PLC Transaction History
Thompson Investment Management, Inc.
- $652 Million
- Q1 2025
A detailed history of Thompson Investment Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Thompson Investment Management, Inc. holds 1,321 shares of AZN stock, worth $95,230. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,321
Previous 1,299
1.69%
Holding current value
$95,230
Previous $85,000
14.12%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,393Shares Held
476MCall Options Held
6MPut Options Held
4.4M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.35 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.93 Billion2.53% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.26 Billion0.47% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.73 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.4 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...